Mehta Rupa, Rao Karthik Nagaraja, Nagarkar Nitin M, Aggarwal Akash
Department of Otolaryngology and Head Neck Surgery, All India Institute of Medical Sciences, Raipur, India.
MCh Head Neck Surgery and Oncology, Department of Head and Neck Oncology, All India Institute of Medical Sciences, Raipur, India.
Indian J Surg Oncol. 2021 Dec;12(4):816-821. doi: 10.1007/s13193-021-01447-w. Epub 2021 Sep 8.
Oral cancers are amongst the most common cancers in the Indian subcontinent; in India alone, an estimated 1.2 lakh new patients were diagnosed with it. Reconstruction with free flaps slowly gained popularity over time to become the standard for care for treating large head and neck defects. Flap selection is a complex process; more specifically, the preoperative conditions of patients, the extent of the disease, and the resources available are critical considerations to consider when selecting the best reconstructive technique. It is very well established that certain parts of India, especially the tribal area of Central and southern India, have high prevalence of sickle cell trait (SCT) and sickle cell disease compared to the rest of the country. The sickle cell trait poses a potential increase in morbidity in the perioperative care due to surgical stress. Unfortunately, there are no published articles on the management of a free flap in a case of SCT. Here, in this article, we investigate the issues encountered during the perioperative care in a patient who undergone oral cavity composite resection with free fibula reconstruction. SCT screening must be undertaken mainly to identify, mitigate, and manage the adverse events in the perioperative period. The screening test is very inexpensive and has good sensitivity to detect the heterozygous and homozygous disease. We would recommend screening of all the patients hailing from high-risk endemic areas. The free flap in a case of sickle cell trait is not a contraindication, but a surgeon must understand the nuances in the management of complications in such case. Screening for sickle cell trait followed by perioperative blood transfusions, anticoagulation seems beneficial in a patient undergoing free flaps with sickle cell trait.
口腔癌是印度次大陆最常见的癌症之一;仅在印度,估计就有12万新患者被诊断出患有口腔癌。随着时间的推移,游离皮瓣重建术逐渐受到欢迎,成为治疗大型头颈部缺损的标准治疗方法。皮瓣选择是一个复杂的过程;更具体地说,患者的术前状况、疾病范围和可用资源是选择最佳重建技术时需要考虑的关键因素。众所周知,与印度其他地区相比,印度的某些地区,特别是印度中部和南部的部落地区,镰状细胞性状(SCT)和镰状细胞病的患病率很高。由于手术应激,镰状细胞性状会使围手术期护理的发病率潜在增加。不幸的是,目前尚无关于SCT患者游离皮瓣管理的发表文章。在本文中,我们调查了一名接受口腔复合切除并游离腓骨重建患者围手术期护理中遇到的问题。必须进行SCT筛查,主要是为了识别、减轻和管理围手术期的不良事件。筛查试验非常便宜,对检测杂合子和纯合子疾病具有良好的敏感性。我们建议对所有来自高风险流行地区的患者进行筛查。镰状细胞性状患者的游离皮瓣并非禁忌,但外科医生必须了解此类病例并发症管理中的细微差别。对镰状细胞性状进行筛查,然后进行围手术期输血、抗凝,对接受游离皮瓣手术的镰状细胞性状患者似乎有益。